Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation

Approval Number

国药准字H20253521

Company四川普锐特药业有限公司

Registration Date

March 4, 2025

Drug Information

Generic Name

沙美特罗替卡松吸入粉雾剂

Dosage Form

吸入粉雾剂

Strength

每泡含昔萘酸沙美特罗50μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松250μg，递送剂量为昔萘酸沙美特罗47µg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松231µg

Drug Type

化学药品

Registration Date

March 4, 2025

Company Information

Applicant Company

Company Name四川普锐特药业有限公司

Company Address

四川省成都高新区安泰五路566号

Manufacturing Company

Company Name四川普锐特药业有限公司

Company Address

成都市高新区安泰五路566号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy